Paper3650100
Neutralizing antibodies and the course of HIV-induced disease.
Wendler I and 2 others. AIDS Res Hum Retroviruses, 1987. Cited by 57 papers, by iCite.
Cite this record
ConductScience Library. Neutralizing antibodies and the course of HIV-induced disease. Papers, record 3650100. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3650100
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| AIDS-Related Complex | Major topic |
| Acquired Immunodeficiency Syndrome | Major topic |
| Antibodies, Viral | Major topic |
| HIV | Major topic |
| Cytopathogenic Effect, Viral | |
| Humans | |
| Neutralization Tests | |
| Viral Envelope Proteins |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 18197170 | The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus. | Nat Rev Microbiol | 2008 | https://conductscience.org/library/papers/18197170 | PubMed |
| 9371609 | Identification of the V1 region as a linear neutralizing epitope of the simian immunodeficiency virus SIVmac envelope glycoprotein. | J Virol | 1997 | https://conductscience.org/library/papers/9371609 | PubMed |
| 9060635 | Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1. | J Virol | 1997 | https://conductscience.org/library/papers/9060635 | PubMed |
| 8464405 | Pathogenesis of human immunodeficiency virus infection. | Microbiol Rev | 1993 | https://conductscience.org/library/papers/8464405 | PubMed |
| 8394444 | Early events in immune evasion by the lentivirus maedi-visna occurring within infected lymphoid tissue. | J Virol | 1993 | https://conductscience.org/library/papers/8394444 | PubMed |
| 8107199 | Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated. | J Virol | 1994 | https://conductscience.org/library/papers/8107199 | PubMed |
| 7583913 | Presence of neutralizing antibodies to heterologous human immunodeficiency virus type 1 isolates in sera of infected individuals is not predictive of rate of disease progression. | Clin Diagn Lab Immunol | 1995 | https://conductscience.org/library/papers/7583913 | PubMed |
| 3282628 | Vaccine and antiviral strategies against infections caused by human immunodeficiency virus. | CMAJ | 1988 | https://conductscience.org/library/papers/3282628 | PubMed |
| 3208445 | Neutralizing antibodies in relation to antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus type I. | Clin Exp Immunol | 1988 | https://conductscience.org/library/papers/3208445 | PubMed |
| 3172340 | Simian immunodeficiency virus from African green monkeys. | J Virol | 1988 | https://conductscience.org/library/papers/3172340 | PubMed |
| 2479014 | Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp120 epitopes correlates with the uninfected status of children born to seropositive mothers. | Proc Natl Acad Sci U S A | 1989 | https://conductscience.org/library/papers/2479014 | PubMed |
| 2462060 | Human immunodeficiency virus type 1-neutralizing monoclonal antibodies which react with p17 core protein: characterization and epitope mapping. | J Virol | 1989 | https://conductscience.org/library/papers/2462060 | PubMed |
| 1901833 | Serological markers as prognostic criteria for the course of HIV infection. | Infection | 1991 | https://conductscience.org/library/papers/1901833 | PubMed |
| 1696634 | Analysis of a highly immunodominant epitope in the human immunodeficiency virus type 1 transmembrane glycoprotein, gp41, defined by a human monoclonal antibody. | J Virol | 1990 | https://conductscience.org/library/papers/1696634 | PubMed |
| 1601999 | Vertical transmission of human immunodeficiency virus (HIV) infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type 1. | J Clin Invest | 1992 | https://conductscience.org/library/papers/1601999 | PubMed |
| 1572084 | B cell responses to HIV and the development of human monoclonal antibodies. | Clin Exp Immunol | 1992 | https://conductscience.org/library/papers/1572084 | PubMed |
| 1370558 | Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120. | J Virol | 1992 | https://conductscience.org/library/papers/1370558 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3650100
GET https://conductscience.org/api/papers/v1/3650100/authors